PGY4 AP/CP @UWlabmedpath 🇺🇸 26-27 @StanfordPath #GYNpath fellow 😍 @RCSI_irl 22 alum 🇮🇪 Creator of #PathWebinarPearls 🧵I Trainee #PathTweetAward 23&24

Seattle, WA
Joined September 2020
Carol N. Rizkalla, MD retweeted
#GUpath TURBT from today's signout showing what I call "3/4 rule" of MP invasion (if tumor is three-quarters of the way around MP bundle but not technically IN bundle, I'll still call it MP invasion) for good measure, lower power shots show more typically pattern MP invasion
3
11
35
2,409
Carol N. Rizkalla, MD retweeted
#GUpath🧩time! 80ish M undergoes TURP ❓🔬🤔
4
11
32
2,086
Carol N. Rizkalla, MD retweeted
I'm honored to receive this @StanfordPath award! helps solidify my mantra: #ABT (always be teaching) also, go #GUpath‼️💪🏼🔬
24
6
2
123
5,874
Carol N. Rizkalla, MD retweeted
Routine minimum IHC for metastatic tumors - prostate cancer - Prostate markers: NKX3.1, AR - Neuroendocrine markers: Synaptophysin, chromogranin, and INSM1 - Others to consider: Ki67, p53, RB Per NCCN, all metastatic biopsies should undergo NGS testing. Dr. Chan #USCAP2026 #pathology #PathX #PathTwitter
21
56
2,192
A little over two years ago, I stood in front of the @LoyolaStritch Class of 2026 as their M2 pathology instructor before heading to Michigan. Last week, I had the profound honor of returning to deliver their commencement address. Full circle in the best possible way. I spoke to them about curiosity, wonder, resilience. About the bone marrow, of course (I promise it made sense). I want them to remember that medicine is still sacred work. In a world moving faster and louder every day, I hope they protect the part of themselves that still pauses in awe at the privilege of caring for another human being. To the Stritch School of Medicine Class of 2026: thank you for allowing me to be a small part of your journey, both then and now. Watching you cross that stage was a privilege I will never forget. Never stop exploring. youtu.be/JRSdL1LpDrg?si=IuhG…
2
5
1
31
6,625
Carol N. Rizkalla, MD retweeted
📣 Join us for the next @GU_Path_Society Virtual Education Series! 🧬 Tumor Staging in GU Pathology (Part 1) 📅 June 23, 2026 | ⏰ 12–1:30 PM EST Featuring: 👨‍⚕️ Dr. Tekin @buraktekinmd 👨‍⚕️ Dr. Sangoi @slusagar 👩‍⚕️ Dr. Siegmund Register now 👉 us02web.zoom.us/webinar/regi…
23
41
2,751
Carol N. Rizkalla, MD retweeted
#GUpath orchiectomy w/embryonal carcinoma showing LVI in main specimen spermatic cord shows discontinuous (non LVI here) involvement current AJCC calls this pM1, but NCCN seemingly blows this off, saying to instead stage as pT3 🤔🔬🙈⁉️ ⏬cont'd⏬
1
10
24
1,911
Carol N. Rizkalla, MD retweeted
#GUpath: adult M, renal mass bx before you embark down growing DDx of pink renal tumors, don't forgot about angiomyolipoma! IMO, cathepsinK is the best #IHCpath here, > than melanA/HMB45
2
13
38
3,008
Carol N. Rizkalla, MD retweeted
Yet another sneaky treacherous one... Keep your eyes wide open, children. #breastpath
8
14
57
2,756
Carol N. Rizkalla, MD retweeted
first time trainee sees his/her paper out in press
2
17
1,445
Carol N. Rizkalla, MD retweeted
#PathQuiz 🔬🧬 A) Chromophobe RCC B) Oncocytoma C) SDH-Deficient RCC D) Low-grade Oncocytic Tumor #Pathology #GUPath #KidneyPath
2
29
80
5,949
🧩 Bloody Bladder When signing out this lesion, what clinical question comes to mind? 👨 65-year-old man • Prior prostate adenocarcinoma? 👩 45-year-old woman • Prior cervical carcinoma? not always. So… what’s the diagnosis? 🤔 #DxMindMap #BladderTumor #PathTwitter #JHUPath
4
9
2
32
4,174
Carol N. Rizkalla, MD retweeted
while not formally staged since not "carcinoma", rarely can you get "pT3a" histology🔬 (vascular/adipose/pelvicalyceal invasion) doesn't change Dx! (but if occurs, probably worth confirming Dx by doing NGS to rule out DDx entities) PMID: 38422612
11
24
1,007
Carol N. Rizkalla, MD retweeted
✅ Endometrial atypical hyperplasia / EIN 🎯 • Defined as a geographical lesion where the glandular volume exceeds the stromal volume. • Shows significant cytological atypia (loss of polarity, rounded nuclei) distinct from background glands. • It is a clonal proliferation and a direct precursor to low-grade endometrioid adenocarcinoma. • Often associated with loss of PTEN or PAX2 expression.
1
5
31
1,417
Carol N. Rizkalla, MD retweeted
Endometrial Adenocarcinoma: Depth of Invasion – Challenging scenarios 🔬 ✅ Avoid the cornu – naturally thinner, can lead to over-staging ✅ Tumor in a leiomyoma? Include it in your invasion measurement if it’s the deepest point ✅ Invasion from adenomyosis in outer half? Stage as pT1b (per ICCR & ISGyP). Dr. Joehlin / Dr. McGregor - Short course #USCAP2026 #pathology #PathX #PathTwitter
3
54
134
4,007
The International Society of Gynecological Pathologists Education Committee proudly congratulates the recipients of ISGyP trainee presentation awards at USCAP Texas, March 2026! 🎉👏 #Pathology #Gynaepath #Gynpath #PathTwitter
5
1
13
1,567
Carol N. Rizkalla, MD retweeted
no better way to start a Monday than with #beautyinb9 #GUpath nephrogenic adenoma! simple prostatectomy for BPH, remote h/o 3+3 prostatic adenocarcinoma
1
14
35
1,625
Carol N. Rizkalla, MD retweeted
#PathQuiz 🔬🦴 _______ rearrangement A) USP6 B) FN1 C) COL12A1 D) GRM1 #Pathology #SoftTissuePath #BonePath #MolecularPath Clue in caption 🧐 @IARCWHO
1
9
21
2,032
Carol N. Rizkalla, MD retweeted
EWSR1::____ fusion A) WT1 B) CREB1 C) ATF1 D) FLI1 #PathQuiz 🔬 #Pathology #SoftTissuePath #MolecularPath Clue in caption 🧐
2
16
44
3,592
Carol N. Rizkalla, MD retweeted
#PathQuiz 🔬 A) Endometrial polyp B) Adenomyoma C) Low-grade endometrioid carcinoma D) Atypical polypoid adenomyoma #Pathology #GYNPath @IARCWHO Clue in caption 🧐
1
20
65
5,482